25731-1-AP
antibody from Proteintech Group
Targeting: CERK
dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25731-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- CERK antibody
- Antibody type
- Polyclonal
- Description
- CERK antibody (Cat. #25731-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Identification of the potential role of PANoptosis-related genes in burns via bioinformatic analyses and experimental validation.
The PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferation.
Chen J, Zhou Q, Cao Y, Tang X, Zhang Y, Wang L, Li J, Liang B
Burns : journal of the International Society for Burn Injuries 2025 Jun;51(5):107477
Burns : journal of the International Society for Burn Injuries 2025 Jun;51(5):107477
The PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferation.
Shi J, Li Z, Sun X, Zhao D, Kang S, Cao F, Zhang Z, Zhang C
Ecotoxicology and environmental safety 2025 Jun 1;297:118268
Ecotoxicology and environmental safety 2025 Jun 1;297:118268
No comments: Submit comment
No validations: Submit validation data